Incannex Enlists Investigators for Study of IHL-42X for Sleep Apnea
Incannex Healthcare recruited two lead principal investigators for a phase 2/3 clinical trial investigating IHL-42X for the treatment of OSA.
Source: sleepreviewmag.com
Search Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Search Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Search Trials Today - Breaking & Trending Today
Incannex Healthcare Ltd appoints principal investigators for obstructive sleep apnoea trial featuring IHL-42X
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has appointed two highly experienced lead principal investigators (PIs) for its Phase 2/3 clinical trial of...
Source: proactiveinvestors.com
Public Announcement (NASDAQ: IXHL) (ASX: IHL) - Form 6-K
Public Announcement Incannex Appoints Principal Investigators for IHL-42X Phase 2/3 Clinical Trial ... | June 16, 2023
Source: marketscreener.com